Company page

Scynexis, Inc.

Scynexis, Inc. is a public company traded under the ticker SCYX in the American market. The company has a market capitalization of approximately $37 million. Scynexis focuses on developing innovative therapies for serious infections, particularly in the area of antifungal treatments.